| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 60607-34-3 | 奧沙米特; 苯咪唑嗪; 1-[-3-[4-(二苯基甲基)-1-哌嗪基]丙基]-2-苯并咪唑酮 | Oxatomide; 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-2H-benzimidazol-2-one |  | C27H30N4O | 詳情 | 供應商 |
| 65277-42-1 | 酮康唑; 順-1-乙�；�-4-[4-[[2-(2,4-二氯苯基)-2-(1H-咪唑-1-基甲基)-1,3-二氧戊環(huán)-4-基]甲氧基]苯基]哌嗪 | Ketoconazole; cis-1-Acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine |  | C26H28Cl2N4O4 | 詳情 | 供應商 |
| 68741-18-4 | 布替利嗪; 2-丁基-5-[[4-(二苯甲基)哌嗪-1-基]甲基]-1-乙基苯并咪唑 | Buterizine; 2-Butyl-5-[[4-[di(phenyl)methyl]piperazin-1-yl]methyl]-1-ethylbenzimidazole |  | C31H38N4 | 詳情 | 供應商 |
| 167933-07-5 | 氟立班絲氨; 3-[2-[4-[4-(三氟甲基)苯基]哌嗪-1-基]乙基]-1H-苯并咪唑-2-酮 | Flibanserin; 3-[2-[4-[4-(Trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one |  | C20H21F3N4O | 詳情 | 供應商 |
| 224785-91-5 | 瓦地拉非鹽酸鹽; 鹽酸伐地那非; 2-[2-乙氧基-5-(4-乙基哌嗪-1-基)磺酰苯基]-5-甲基-7-丙基-1H-咪唑并[5,1-f][ | Vardenafil hydrochloride; 2-[2-Ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one hydrochloride |  | C23H33ClN6O4S | 詳情 | 供應商 |
| 224789-15-5 | 瓦地那非二鹽酸鹽; 伐地那非二鹽酸鹽; 2-[2-乙氧基-5-(4-乙基-哌嗪-1-磺酰基)苯基]-5-甲基-7-丙基-3H-咪唑[5, | Vardenafil dihydrochloride; 1-[[3-(1,4-Dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-piperazine dihydrochloride; Levitra |  | C23H34Cl2N6O4S | 詳情 | 供應商 |
| 915769-50-5 | 多韋替尼; 4-氨基-5-氟-3-[6-(4-甲基-1-哌嗪基)-1H-苯并咪唑-2-基]-2(1H)-喹啉酮2-羥基丙酸鹽一水物 | Dovitinib; 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone 2-hydroxypropanoate hydrate (1:1:1) |  | C21H21FN6O.C3H6O3.H2O | 詳情 | 供應商 |
| 1095382-05-0 | CCT-137690; 3-[[4-[6-溴-2-[4-(4-甲基哌嗪-1-基)苯基]-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]甲基]-5-甲基? | CCT 137690 | 無 | 詳情 | 供應商 | |
| 52254-38-3 | CCT-137690; 3-[[4-[6-溴-2-[4-(4-甲基哌嗪-1-基)苯基]-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]甲基]-5-甲基? | 2-Methyl-1-tetradecene |  | C15H30 | 詳情 | 供應商 |
| 1001645-58-4 | SRT1720; N-[2-[3-(1-哌嗪甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-喹喔啉甲酰胺鹽酸鹽 | SRT1720; SRT1720; N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide hydrochloride; N-(2-(3-(piperazin-1-ylMethyl)iMidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxaMide hydrochloride | 無 | C25H24ClN7OS | 詳情 | 供應商 |
| 890090-75-2 | 4-[[4,5-雙(4-氯苯基)-4,5-二氫-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮; 4-[[4,5-雙(4-氯苯基)-4,5-二氫-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮 | 4-[[4,5-Bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-piperazinone; 4-[[4,5-Bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-piperazinone; 4-(4,5-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydro-1H-imidazole-1-carbonyl)piperazin-2-one; RG7112, R7112; RO5045337 |  | C30H30Cl2N4O4 | 詳情 | 供應商 |
| 929095-18-1 | 5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺; 5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺; GSK461364; 5-[6-[(4-甲基-1-哌嗪基)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩甲酰胺 | 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide; 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide; GSK-461364; (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide; GSK-461364A; GSK461364(GSK-461364) |  | C27H28F3N5O2S | 詳情 | 供應商 |
| 942947-93-5 | 2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺; 2-[4-[6-氯-2-(4-二甲基氨基苯基)-3H-咪唑并[4,5-B]吡啶-7-基]哌嗪-1-基]-N-(噻唑-2-基)乙酰胺 | CCT129202; CCT129202; 2-[4-[6-Chloro-2-(4-dimethylaminophenyl)-3H-imidazo[4,5-b]pyridin-7-yl]piperazin-1-yl]-N-(thiazol-2-yl)acetamide | 無 | C23H25ClN8OS | 詳情 | 供應商 |
| 1255517-76-0 | PF-4708671; 2-[[4-(5-乙基-4-嘧啶基)-1-哌嗪基]甲基]-6-(三氟甲基)-1H-苯并咪唑 | 2-[[4-(5-Ethylpyrimidin-4-yl)piperazin-1-yl]methyl]-5-(trifluoromethyl)-1H-benzo[d]imidazole; 2-[[4-(5-Ethylpyrimidin-4-yl)piperazin-1-yl]methyl]-5-(trifluoromethyl)-1H-benzo[d]imidazole; PF 4708671; 2-[[4-(5-ethyl-4-pyriMidinyl)-1-piperazinyl]Methyl]-6-(trifluoroMethyl)-1H-benziMidazole; PF4708671/PF-4708671 |  | C19H21F3N6 | 詳情 | 供應商 |
| 675576-97-3 | 4-[[(4R,5S)-4,5-雙(4-氯苯基)-4,5-二氫-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮; 4-[[(4R,5S)-4,5-雙(4-氯苯基)-4,5-二氫-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮 | Nutlin-3b; Nutlin-3b; 4-[[(4R,5S)-4,5-Bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-piperazinone | 無 | C30H30Cl2N4O4 | 詳情 | 供應商 |